Skip to main content

Table 3 Distribution of baseline information by adverse clinical outcomes of COVID-19

From: Can initial chest CT scan predict status and clinical outcomes of COVID-19 infection? A retrospective cohort study

Variables ICU admission P value Death P value Disease severitya P value
Yes No Yes No Moderate Severe Critical
Age (years), mean ± SD 56.64 ± 13.66 56.51 ± 15.24 0.923 62.38 ± 13.04 54.79 ± 14.80 < 0.001 57.20 ± 15.46 54.39 ± 14.77 57.96 ± 13.07 0.084
Sex, n (%)
Males 108 (66.3) 209 (58.1) 0.075 78 (64.5) 239 (59.5) 0.323 141 (58.3) 92 (59.4) 84 (66.7) 0.273
Females 55 (33.7) 151 (41.9)   43 (35.5) 163 (40.5)   101 (41.7) 63 (40.6) 42 (33.3)  
CVDs, n (%)
Yes 79 (48.5) 140 (38.9) 0.040 58 (47.9) 161 (40.0) 0.123 98 (40.5) 55 (35.5) 66 (52.4) 0.014
No 84 (51.5) 220 (61.1)   63 (52.1) 241 (60.0)   144 (59.5) 100 (64.5) 60 (47.6)  
Asthma/COPD, n (%)
Yes 27 (16.6) 25 (6.9) 0.001 16 (13.2) 36 (9.0) 0.169 18 (7.4) 9 (5.8) 25 (19.8) < 0.001
No 136 (83.4) 335 (93.1)   105 (86.8) 366 (91.0)   224 (92.6) 146 (94.2) 101 (80.2)  
Diabetes, n (%)
Yes 52 (31.9) 78 (21.7) 0.012 35 (28.9) 95 (23.6) 0.237 34 (14.0) 52 (33.5) 44 (34.9) < 0.001
No 111 (68.1) 282 (78.3)   86 (71.1) 307 (76.4)   208 (86.0) 103 (66.5) 82 (65.1)  
  1. CVDs cardiovascular diseases, COPD chronic obstructive pulmonary disease
  2. aBased on the World Health Organization criteria